Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial

Author:

Pinto Navin1ORCID,DuBois Steven G.2ORCID,Marachelian Araz3,Diede Scott J.4,Taraseviciute Agne1,Glade Bender Julia L.5,Tsao-Wei Denice6,Groshen Susan G.6,Reid Joel M.7,Haas-Kogan Daphne A.8,Reynolds C. Patrick9,Kang Min H.9,Irwin Meredith S.10ORCID,Macy Margaret E.11ORCID,Villablanca Judith G.3ORCID,Matthay Katherine K.1213,Park Julie R.1

Affiliation:

1. Seattle Children's Hospital; University of Washington; Seattle Washington

2. Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School; Boston Massachusetts

3. Children's Hospital Los Angeles; University of Southern California Keck School of Medicine; Los Angeles California

4. Global Clinical Development-Oncology; Merck Research Laboratories; North Wales Pennsylvania

5. Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation; Columbia University Medical Center; New York City New York

6. Department of Preventative Medicine; University of Southern California; Los Angeles California

7. Department of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic; Rochester Minnesota

8. Department of Radiation Oncology; Brigham and Women's Hospital; Harvard Medical School; Boston Massachusetts

9. Cancer Center and Cell Biology; Texas Tech University Health Sciences Center School of Medicine; Lubbock Texas

10. Division of Haematology/Oncology; The Hospital for Sick Children; University of Toronto; Toronto Canada

11. Pediatric Hematology/Oncology/Bone Marrow Transplant; University of Colorado Anschutz Medical Campus; Aurora Colorado

12. UCSF Benioff Children's Hospital; University of California; San Francisco California

13. UCSF School of Medicine; University of California; San Francisco California

Funder

National Institutes of Health

National Cancer Institute

St. Baldrick's Foundation

Children's Neuroblastoma Cancer Foundation

Ben Towne Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3